Mon, April 6, 2020
Fri, April 3, 2020
Thu, April 2, 2020
Wed, April 1, 2020
Tue, March 31, 2020

David Risinger Maintained (AMRX) at Hold with Decreased Target to $3 on, Apr 2nd, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-3-on-apr-2nd-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Risinger of Morgan Stanley, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Decreased Target from $5 to $3 on, Apr 2nd, 2020.

David has made no other calls on AMRX in the last 4 months.



There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Maintained at Hold with Increased Target to $4 on, Thursday, January 2nd, 2020

Publication Contributing Sources